Orbapin Tablet 5 mg+20 mg is a combination antihypertensive medication containing Amlodipine Besilate 5 mg and Olmesartan Medoxomil 20 mg, designed to effectively manage high blood pressure (hypertension) in adults. Hypertension is a chronic condition that can increase the risk of heart attack, stroke, and kidney disease if left uncontrolled. By combining two complementary mechanisms, Orbapin provides enhanced blood pressure control and reduces cardiovascular risk.
Amlodipine Besilate is a calcium channel blocker that relaxes blood vessels, reducing resistance and improving blood flow.
Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that prevents vasoconstriction and promotes sodium and water balance, lowering blood pressure.
This dual-action therapy is particularly beneficial for patients whose blood pressure is not adequately controlled with monotherapy and for those who require convenient once-daily dosing.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Effective reduction of systolic and diastolic blood pressure
Combines two complementary mechanisms for superior antihypertensive effect
Reduces the risk of cardiovascular events in hypertensive patients
Once-daily dosing improves adherence and convenience
Helps protect the heart, kidneys, and blood vessels from hypertensive damage
Suitable for long-term management of essential hypertension
Orbapin Tablet works through the combined action of its active ingredients:
Amlodipine Besilate 5 mg:
Inhibits calcium ion influx into vascular smooth muscle and cardiac muscle.
Causes vasodilation of peripheral arteries, reducing vascular resistance and lowering blood pressure.
Improves oxygen delivery to the heart and reduces cardiac workload.
Olmesartan Medoxomil 20 mg:
Blocks angiotensin II type 1 receptors, preventing vasoconstriction.
Reduces aldosterone secretion, leading to decreased sodium and water retention.
Enhances long-term blood pressure control and reduces cardiovascular strain.
Synergistic Effect:
The combination targets two different pathways of blood pressure regulation, producing a more effective and sustained antihypertensive effect than either agent alone.
Orbapin Tablet 5 mg+20 mg is indicated for:
Management of essential hypertension in adults
Patients not adequately controlled with monotherapy
Long-term prevention of hypertension-related cardiovascular complications
Reducing the risk of stroke, heart attack, and kidney damage associated with high blood pressure
Recommended dose: One tablet once daily, orally, with or without food, as prescribed by a healthcare professional.
Swallow the tablet whole with water; do not crush or chew.
Blood pressure should be monitored regularly to assess response to therapy.
Adjustments may be made based on patient response and tolerance.
Not recommended for patients with severe hypotension, pregnancy, or known hypersensitivity to Amlodipine or Olmesartan.
Use caution in patients with renal or hepatic impairment.
Inform your doctor about all medications being taken to avoid interactions.
Avoid sudden discontinuation to prevent rebound hypertension.
Monitor kidney function and electrolytes during long-term use.
Common side effects may include:
Dizziness or lightheadedness
Headache
Flushing
Peripheral edema (swelling of hands or feet)
Mild gastrointestinal disturbances
Serious side effects are rare but may include hypotension, kidney dysfunction, or severe allergic reactions. Seek immediate medical attention if these occur.
Store below 30°C in a dry, cool place, protected from light and moisture. Keep out of reach of children.
Orbapin Tablet 5 mg+20 mg offers a safe and effective combination therapy for the long-term management of hypertension, combining the complementary effects of Amlodipine and Olmesartan to reduce blood pressure and protect cardiovascular health.
Login Or Registerto submit your questions to seller
No none asked to seller yet